AI주식인사이트AI Stock Insight
C

엠에프씨

432980KOSDAQ

47.5 / 100

Reference Date: 2026-09-08

Financial Score17.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly down 3.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

MFC is a specialized company in the development and production of active pharmaceutical ingredients (APIs) and key materials (e.g., KSM, PI), expanding its business across generic drugs and improved new drug materials. Key products include APIs for treating hypertension and hyperlipidemia, as well as improved new drug materials (e.g., MFC-TM001, MFC-GM001), leveraging patented crystal form and salt development technologies to enhance market competitiveness.

Number of Employees

65people

Average Salary

64.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
24.61Industry Average 15.001.5Point

1.6x industry avg (risky)

PBR
0.72Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
2.82Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
0.40Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20251.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲0.9% (1-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼79.7% (1-year basis)

ROE Trend
0.0 / 4

Avg ROE -1.2% (improving, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 2,535Won52-week high 4,23052-week low 2,480
1-month return2.0Point

1m -3.24% (slight drop)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14